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ABSTRACT We have transfected MAH cells, an immor-
talized sympathoadrenal progenitor cell line, with a plasmid
encoding the 140-kDa Trk protein, a nerve growth factor
(NGF) receptor with protein-tyrosine kinase activity. NGF
promotes neurite outgrowth and proliferation from such cells,
indicating that Trk is sufficient to mediate such responses in the
absence of significant levels of the endogenous 75-kDa low-
affinity NGF receptor (p75). These initial NGF responses are
indistinguishable from those evoked by basic fibroblast growth
factor (bFGF). However, NGF is sufficient to promote terminal
differentiation of a '4% of Irk-transfected MAH cells to
postmitotic, NGF-dependent neurons, whereas all cells even-
tually die in medium with bFGF. Other environmental signals
(such as depolarization or ciliary neurotrophic factor) can
cooperate with NGF to enhance production of postmitotic
NGF-dependent neurons in trk-transfected MAH cells. The
terminal differentiation of sympathetic neurons thus involves
sequential and cooperative actions of different growth and
neurotrophic factors, as well as cell-intrinsic changes in the
response to these factors.
In vertebrates, neuronal differentiation and survival are
controlled by polypeptide growth and neurotrophic factors,
as well as by cytokines (1, 2). Studies of normal and immor-
talized progenitors in the sympathoadrenal lineage of the rat
have demonstrated a relay or cascade offactors that controls
neurogenesis (for review, see ref. 3). Basic fibroblast growth
factor (bFGF) can act to promote the proliferation and initial
neuronal differentiation of the cells but cannot support their
survival (4-6). However, in chromaffin cells bFGF appears
to induce a dependence upon nerve growth factor (NGF),
which in turn supports the subsequent maturation and sur-
vival of postmitotic sympathetic neurons (5). Thus, bFGF
can act as a "progression factor," while NGF acts as a
trophic factor. In addition, proliferating sympathetic neuro-
blasts respond to mitogens such as insulin-like growth factor
I (7-9), which may act as interim survival factors together
with other neurotrophins such as NT-3 (10, 11).
While the actions of neurotrophic factors on neural pre-
cursor cells have been studied intensively, less is known
about the regulation and function of the membrane receptors
that are required to respond to these factors. Two receptors
for NGF have been identified: the receptor tyrosine kinase
Trk and the low-affinity NGF receptor p75 (for reviews, see
refs. 12 and 13). Several lines of genetic and immunologic
evidence have suggested that p75 is not necessary for a
functional response to NGF and that Trk is sufficient for
some functional responses in nonneuronal cells (for reviews,
see refs. 12-15). However, it has been more difficult to
establish whether Trk is sufficient for biological responses to
NGF in neuronal cells, because most neuronal cell lines used
in studies of Trk function, such as PC12 rat pheochromocy-
toma cells and their mutants, contain endogenous p75 (16,
17). MAH, a v-myc-inmmortalized sympathoadrenal progen-
itor cell line that does not respond detectably to NGF (6),
expresses undetectable levels of p75 protein as assayed by
immunocytochemistry (18) or affinity crosslinking (19). With
reverse transcription (RT)-PCR, an extremely low level of
p75 mRNA is e.tected, corresponding to 1/1000th the level
in PC12 cells (19). MAH cells grown in the absence of
dexamethasone also express little or no trk mRNA (18, 19).
Previously, we demonstrated that membrane depolariza-
tion of MAH cells with 40 mM KCl induced expression of
endogenous trkmRNA, but not p75 protein (18). Depolarized
MAH cells also exhibited a functional response to NGF (18).
However, it remained unclear whether the induction of trk
expression was sufficient to account for the effects of NGF
on these cells. For example, depolarization might also induce
other components of the signal transduction machinery
which are necessary for a functional response to NGF. To
examine the function of Trk in MAH cells lacking significant
levels of p75 without the complicating influence of depolar-
ization, we have introduced a human trk cDNA into these
cells by transfection and studied their responses to NGF.
MATERIALS AND METHODS
Culture and Transfection of MAH Cells. MAH cells were
maintained in L15-CO2 medium with 10%o fetal bovine serum
and 5 ,uM dexamethasone (6). In all experiments involving
differentiation of the cells, dexamethasone was removed
from the medium. MAH cells were transfected by the calcium
phosphate precipitation procedure with an expression plas-
mid containing a human Trk cDNA (20) and the histidinol
dehydrogenase gene as a selectable marker (21). This human
cDNA encodes the Al isoform of Trk, which is expressed
predominantly in nonneural tissues (34); the recently de-
scribed TrkA11 isoform is neuron-specific but both isoforms
have identical activities in fibroblast survival assays (34).
Because of the low transfection efficiencies obtained
(--0.1%), it was not practical to perform transient-expression
assays or to isolate individual clones of stably transfected
cells. Rather, pools ofhistidine-resistant cells were expanded
until sufficient numbers were achieved to perform an exper-
iment (2-3 weeks), and the cell population was then used in
its entirety. Each experiment was performed at least twice
with independently generated pools of transfectants. NGF
was routinely used at 50 ng/ml, and ciliary neurotrophic
factor (CNTF) at 10 ng/ml.
Abbreviations: bFGF, basic fibroblast growth factor; CNTF, ciliary
neurotrophic factor; LDH, lactate dehydrogenase; MAH[trkhul
cells, MAH cells transfected with human trk AI cDNA; NGF, nerve
growth factor; RT, reverse transcription.
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PCR Assays. trk mRNA in transfected MAH cells was
assayed by a semiquantitative RT-PCR method (22). The
oligodeoxynucleotide primers used were primer 1 (5'-
ATGAGACCAGCTTCATC-3'), primer 2 (5'-CTCCTTCTC-
GCCAGTGG-3'), and primer 3 (5'-GCTCCCACTTGAGAA-
TG-3'). Primer 2 detects an alternatively spliced exon (34)
present in the form of rat trk mRNA expressed in PC12 and
depolarized MAH cells, but not in the human trk cDNA used
for transfection (see Fig. 1A Inset). PCR conditions were as
follows: denaturation, 1 min at96C; annealing, 1 min at 52TC;
extension, 1 min 10 sec at 72TC. Amplification was performed
for 35 cycles, which was within the linear range of the assay.
Biological Assays. Cell number was determined with a
lactate dehydrogenase (LDH) colorimetric assay (23). Alter-
natively, the number of cells or cell clusters was directly
determined by counting microscopic fields. Neurite out-
growth was scored with a minimum length of 1 cell body
diameter as a cutoff. [3H]Thymidine labeling was performed
by incubating cultures for 4 hr with [methyl-3H]thymidine (1
ACi/ml; 1 tCi = 37 kBq) and then assaying trichloroacetic
acid-precipitable radioactivity. Immunocytochemical label-
ing was performed as described elsewhere (6).
RESULTS
MAH Cells Expressing Exogenous trk mRNA Display Func-
tional Responses to NGF. Expression of endogenous and
transfected trk mRNA in MAH cells was measured by
RT-PCR (Fig. 1). We used one set of primers that detected
both rat and human trk mRNAs (Fig. 1A, primers 1 and 3),
and another set (primers 2 and 3) that detected an alterna-
tively spliced neural-specific isoform of rat trk mRNA [trkAuj
(34)] expressed in PC12 cells (Fig. 1A Inset, lane PC12; Fig.
1B, lane 5) and depolarized MAH cells (Fig. 1A Inset, lane
MAH + 40 mM K+). Primers 2 and 3 do not detect human
trkAj message encoded by the expression plasmid (Fig. 1A
Inset, lane hutrk Plasmid). Neither endogenous rat nor hu-
man trkA1 sequences were detected in control MAH cells
grown for 24 hr in the absence of dexamethasone (18) (Fig.
1B, lanes 8 and 9). However, in MAH[trkhu] cells a 565-bp
PCR product was detected as expected (Fig. 1B, lane 12), and
no endogenous rat trk mRNA was detected (Fig. 1B, lane 11).
Pools of stably transfected MAH[trkhul cells displayed two
short-term responses to NGF (visible in 24-36 hr): neurite
outgrowth and extensive proliferation (Figs. 2A and 3A and
data not shown). Such responses were dependent upon
addition ofNGF and were not observed in cells transfected
with human p75 or vector alone (Fig. 2D; Fig. 3A and B; data
not shown). Moreover, NGF appeared to have a trophic
effect, as few cells remained after 5 days without NGF
treatment (Fig. 3 B and D). Importantly, the short-term NGF
responses observed in MAH[trkhul cells were similar to those
seen in depolarized MAH cells (Fig. 2B). This suggests that
the induction ofendogenous trk is sufficient to account for the
NGF responsiveness displayed by depolarized MAH cells.
As in depolarized MAH cells (18), no expression of endog-
enous p75 was detected by immunolabeling in MAH[trkhu]
cells even after 5 days (data not shown), confirming that trk
expression was sufficient for a biological response to NGF in
the absence of p75 in these neuronal cells. Finally, over the
first 3 days, the responses to NGF in MAH[trkhu] cells were
similar to those observed in response to bFGF (Fig. 2C and
Fig. 3 C and D). This suggests that when expression of trk is
forced in an immature neuronal precursor cell, NGF can act
on such cells as a mitogen (24) and differentiation factor, like
bFGF.
To examine in more detail the relative contributions of trk
expression to proliferation and survival, we performed
[3H]thymidine labeling experiments. Like bFGF, NGF stim-
ulated thymidine incorporation into MAH[trkhu] cells over
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FIG. 1. Expression of human trk mRNA in transfected MAH
cells. (A) Location of the two primer sets used for trk RT-PCR.
Primer 2 anneals to an alternatively spliced miniexon (34) expressed
in rat PC12 cells and depolarizedMAH cells (Inset); note that the two
bands detected in these cells do not represent two different tran-
scripts but, rather, represent two different-size PCR products de-
rived from the same cDNA template. The miniexon is absent from
the human trkcDNA used (hutrk plasmid). Primers 1 and 3 hybridize
equally well to both human and rat trk sequences (J.M.V., unpub-
lished data; see B, lane 6). (B) RT-PCR with P-actin primers (lanes
1-3), trk primers 2 and 3 (lanes 4, 5, 7, 8, 10, and 11), or trk primers
1 and 3 (lanes 6, 9, and 12). Approximately 1/20th the amount of
cDNA was used for the actin amplification as for the trk amplifica-
tion; the number of cycles was kept constant at 35. Note that in
human trk-transfectedMAH cells (MAH[trkhu] cells) a 565-bp human
trk RT-PCR product (lane 12) but no endogenous rat product (lane
11) was seen; neither set of primers yielded a product in nontrans-
fected MAH cells (lanes 8 and 9; see also Inset in A). Low levels of
endogenous trk mRNA can be detected in control MAH cells grown
in medium with dexamethasone (18); however, these levels are
insufficient for a functional response to NGF. "No RT" indicates
controls in which reverse transcriptase was omitted from the reac-
tion.
the first 3 days ofculture (Fig. 3C). After that time, thymidine
incorporation appeared to decline. Examination of total cell
number in parallel cultures by LDH assay revealed that much
of this decline was due to cell loss (Fig. 3D), although in the
presence of NGF, it also reflects the accumulation of post-
mitotic cells (Fig. 3 C and D). That some of the cell loss
reflected apoptosis is supported by the fact that it was
inhibited by aurintricarboxylic acid (data not shown), a
nuclease inhibitor that blocks programmed cell death in
sympathetic neurons and PC12 cells (25). However, the rate
of cell loss in bFGF-containing medium was greater than that
in NGF-containing medium for the trk-transfected cells (Fig.
3D) and cell number in medium with NGF eventually stabi-
lized, while in medium with bFGF it decreased to zero (see
below), reflecting the fact that NGF acts as a survival factor
for at least some of the trk-expressing cells, while bFGF does
not.
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FIG. 2. NGF promotes proliferation and neurite outgrowth from MAH[trkhu] cells. Representative fields are shown from cultures treated
for 5 days under the indicated conditions. Quantification is presented in Fig. 3. (A) MAH[trkhu] cells exposed to NGF. (B) Nontransfected MAH
cells depolarized with 40 mM KCl [which induces endogenous trk (18)] and exposed to NGF. (C) Nontransfected MAH cells exposed to bFGF
(10 ng/ml). (D) MAH cells transfected with expression vector lacking the trkcDNA insert and exposed to NGF. These same cultures were fixed
and immunostained for p75; none showed any detectable p75 (data not shown).
Expression of trk Is Sufficient for Terminal Differentiation in
Some Cells. Previous work showed that treatment of MAH
cells with bFGF induced neurite outgrowth in virtually all
cells but was insufficient to support their terminal differen-
tiation (6). In the presence ofboth bFGF and NGF, however,
a very small proportion ofMAH cells (0.01-0.2%) were able
to differentiate to NGF-dependent, postmitotic neurons (6).
These observations raised the question of whether NGF
alone was sufficient to promote terminal differentiation in
trk-expressing MAH cells, or whether bFGF was still nec-
essary. In addition, we wondered whether the forced expres-
sion of high levels of trkmRNA would increase the efficiency
of terminal differentiation beyond that seen in medium with
bFGF and NGF. To address these issues, we examined
MAH[trkhu] cells after long-term (14-day) exposure to NGF.
Following the period of cell death that occurred after the
first week of exposure to NGF (Fig. 3D), the number of
MAH[trkhu] cells eventually stabilized. By 14 days, these
cells had undergone further maturation, exhibiting the cell
soma hypertrophy, enlarged clear nucleus, and prominent
nucleolus characteristic of normal sympathetic neurons (Fig.
4A). These MAH-derived neurons did not divide further,
suggesting that they had become postmitotic. The neurons
expressed tyrosine hydroxylase (Fig. 4B), like undifferenti-
ated MAH cells, indicating that they had maintained their
sympathoadrenal character. In addition, the cells now ex-
pressed endogenous p75 (data not shown), which first be-
came detectable (by immunocytochemistry) at days 10-11.
Most important, the survival of these cells was now depen-
dent upon NGF; upon withdrawal of the neurotrophic factor
the cells died (data not shown). Taken together, these data
indicate that NGF is sufficient to induce not only initial
neuronal differentiation but also maturation ofMAH cells to
NGF-dependent postmitotic neurons, when expression of trk
is forced in these cells.
Forced expression of trk significantly improved the effi-
ciency of generating postmitotic neurons from MAH cells:
whereas only 0.25% of normal MAH cells exposed to bFGF
plus NGF survived after day 5 to become postmitotic neu-
rons, =8% of MAH[trkhu] cells exposed to NGF alone made
this transition (Table 1), a 32-fold enhancement. This sug-
gests that an insufficient induction ofendogenous trk is in part
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FIG. 3. Quantification ofNGF responses of MAH[trkhu] cells. (A
and B) The percentage ofprocess-bearing cell clusters (A) or the total
number of cell clusters (B) was determined after 5 days by direct
microscopic counting. Note that no NGF response is observed in
MAH cells transfected with p75 cDNA but not trk cDNA. Data
represent the mean ± standard deviation of triplicate determinations
from one of several independent experiments. (C) [3H]Thymidine
incorporation was performed by incubating cells with [3H]thymidine
for the last 4 hr of each 24-hr period indicated; sister plates were used
for each time point. Total thymidine incorporation was determined
by scintillation counting. (D) Cell number was determined by LDH
colorimetric assay (23). Note that at days 4-5, [3H]thymidine incor-
poration in bFGF-treated cells is lower than in NGF-treated cells (C),
and total cell number is higher in NGF-treated cells (D), reflecting the
survival-promoting activity of NGF. All cells eventually die in
medium with bFGF, whereas in medium with NGF the population
stabilizes (see Fig. 4 and Table 1).
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FIG. 4. trkA expression is sufficient, but not limiting, for terminal differentiation ofMAH cells in response to NGF. (A and B) MAH[trkhu]
cells exposed to NGF for 14 days; phase-contrast (A) and anti-tyrosine hydroxylase (aTH) immunofluorescence (B) are shown for the same
microscopic field. (C and D) Sequential photographs of the same culture of MAH[trkhuI cells exposed to NGF for 5 days (C) and 14 days (D).
Note that although some terminally differentiated neurons survive to 14 days, they still represent a small proportion of the cells present at day
5 (-8%; see Table 1).
responsible for the low efficiency of terminal differentiation
of normal MAH cells exposed to bFGF plus NGF. However,
the fact that the recovery of postmitotic neurons from MAH-
[trkhu] cells exposed to NGF alone was still only 8% (Fig. 4
C and D; Table 1) suggests that the amount of trk expression
is not the only factor limiting successful terminal differenti-
ation of these cells.
Additional Factors Can Collaborate with NGF to Enhance
Terminal Differentiation of MAH Cells. Both membrane de-
polarization (18) and CNTF (N.I., T. Boulton, Y. Li, J.M.V.,
S. Birren, D.J.A., and G.D.Y., unpublished work) have been
shown to be capable of collaborating with bFGF and NGF to
enhance the terminal differentiation of normal MAH cells to
postmitotic neurons. Depolarization has also been shown to
interact synergistically with growth or neurotrophic factors in
other neuronal systems (26, 27). Although CNTF and depo-
larization appear to act through different pathways (N.I., T.
Boulton, Y. Li, J.M.V., S. Birren, D.J.A., and G.D.Y.,
unpublished work), the data raise the questions of whether
these factors interact specifically with bFGF and whether
their effect is simply to enhance the induction of endogenous
trk. To address these issues, we examined the effect of these
factors on terminal differentiation of MAH[trkhu] cells ex-
posed to NGF in the absence of bFGF.
Table 1. Environmental factors cooperate with NGF to boost the
efficiency of converting MAH [trkhu] cells to postmitotic neurons
% efficiency of
Condition neuron generation*
NGF 8.5 ± 0.35
NGF + CNTF 25 ± 4.3
NGF + 40 mM KCI 43 ± 5.2
NGF + CNTF + 40 mM KCI 70 + 6.0
NGF was used at 50 ng/ml, and CNTF at 10 ng/ml.
* Calculated by counting the total number of neurons on the plate at
day 14 (when the number of cells had stabilized) and dividing that
by the number of cells present at day 5 (the time at which the
maximum number of cells was present in the culture following the
initial proliferative response to NGF). This fraction is expressed as
a percentage. This parameter underestimates the recovery of neu-
rons relative to the day of plating, because of the substantial
proliferation that occurs in the first 5 days (see Fig. 3D). Numbers
represent the mean ± range of duplicate determinations.
Both CNTF and depolarization substantially increased the
percentage of NGF-treated MAH[trkhu] cells present at day
5 that survived to day 14 as postmitotic neurons (Table 1).
The effect of combining these two treatments appeared to be
additive, yielding a 70%o efficiency ofterminal differentiation.
(However, since both CNTF and depolarization are antimi-
totic forMAH cells, some of this increased percent recovery
reflects a depressed cell number at day 5.) These data indicate
that the synergistic effects of CNTF and depolarization are
not specific to bFGF but can be observed with NGF if the
cells are forced to express trk. The total levels of trk mRNA
(human plus endogenous rat trk) expressed at day 5 were
comparable under these various conditions (Fig. 5). Although
depolarization (but not CNTF) induces endogenous rat trk
expression in MAH cells (18), the level of trk mRNA in
depolarized cells is at least 5-fold lower than the level of
human trk mRNA expressed in transfected cells (19). There-
fore, most of the trk mRNA detected in MAH[trkhu] cells
under the various conditions of Fig. 5 was probably human in
origin. Since trk mRNA levels appear to be constant in
MAH[trkhu] cells, an up-regulation of endogenous trk ex-
pression is insufficient to explain the effects ofdepolarization
and CNTF on neuronal differentiation.
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FIG. 5. Depolarization and CNTF do not increase the total
amount oftrkmRNA in MAH[trkhu] cells exposed to NGF. RT-PCR
was performed on total RNA samples extracted from cells after 5
days of treatment in the conditions indicated above the lanes.
Amplification was performed with primers 1 and 3 (Fig. 1A), which
detect both human and endogenous rat trk sequences. X, 3X, and 9X
indicate serial three-fold dilutions of the cDNA template. When
normalized to the actin control (lanes 1-3), the amounts oftrkmRNA
do not differ substantially between the various conditions. K+
indicates depolarized MAH cells.
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DISCUSSION
We have used MAH cells to examine biological responses to
NGF in neuronal cells expressing exogenously introduced trk
but not p75. Two main conclusions can be drawn from this
analysis. (i) The results provide further evidence that Trk is
sufficient to mediate biological responses to NGF in neuronal
precursor cells lacking p75. While several lines of evidence
have suggested that p75 is not necessary for neuronal differ-
entiation or survival (28-30), these studies did not establish
which NGF receptor(s) were functionally involved. Our
findings are consistent with recent results showing that PC12
mutants expressing a truncated form of p75 and reduced
levels of endogenous p75 can still respond to NGF (31) and
that human neuroblastoma cells lacking endogenous p75 can
respond to NGF if transfected with trk (32).
(ii) The results indicate that NGF can act as a progression
factor (like bFGF) as well as a maturation and survival factor
for MAH cells expressing trk. Thus, although bFGF and
NGF normally play sequential and distinct roles in the
differentiation of MAH cells (6), some of these differences
must reflect a change in the cellular context in which their
respective receptors are expressed, rather than an intrinsic
difference in the nature of the signals transmitted by the FGF
and NGF receptors. These results also establish MAH cells
as one of the few cell lines which exhibit progressive changes
in the quality ofthe response to the same growth factor during
differentiation. Finally, the results suggest that the low
efficiency of terminal differentiation of MAH cells to post-
mitotic, NGF-dependent neurons in the presence of bFGF
plus NGF (6, 18) is not simply due to an inefficient induction
of endogenous trk expression but more likely due to a
requirement for other environmental signals that must coop-
erate with NGF in this process.
Several new questions are raised by the present results.
Although our data suggest that trk expression is sufficient for
an NGF response in neuronal cells lacking p75, they do not
exclude the possibility that p75 modulates this response in
some manner. Recent results indicate that coexpression of
p75 in trk-expressing MAH cells both enhances tyrosine
autophosphorylation of Trk and accelerates mitotic arrest
and neuronal maturation (19). The demonstration that NGF
and bFGF each elicit similar early responses from MAH cells
[as they do from PC12 and chromaffin cells (4, 5, 33)] begs the
question ofwhyNGF and notbFGF is able to act as a survival
factor for these cells. A simple explanation is that FGF
receptor expression is rapidly extinguished during neuronal
differentiation; alternatively, Trk protein may activate cell
survival pathways not activated by the FGF receptor. In the
latter case, MAH cells would provide a useful system to
examine the activity ofFGF-NGF receptor chimeras on such
survival responses. Finally, it should be emphasized that
although MAH cells provide a convenient way to dissect
signals and regulatory pathways controlling neuronal differ-
entiation, it remains to be determined how expression of trk
is controlled during normal sympathetic development and
whether signals such as bFGF and CNTF actually function in
vivo in the manner suggested by these in vitro studies.
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